![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 35404 |
FusionGeneSummary for SORL1_CEP164 |
![]() |
Fusion gene information | Fusion gene name: SORL1_CEP164 | Fusion gene ID: 35404 | Hgene | Tgene | Gene symbol | SORL1 | CEP164 | Gene ID | 6653 | 22897 |
Gene name | sortilin related receptor 1 | centrosomal protein 164 | |
Synonyms | C11orf32|LR11|LRP9|SORLA|SorLA-1|gp250 | NPHP15 | |
Cytomap | 11q24.1 | 11q23.3 | |
Type of gene | protein-coding | protein-coding | |
Description | sortilin-related receptorLDLR relative with 11 ligand-binding repeatslow-density lipoprotein receptor relative with 11 ligand-binding repeatsmosaic protein LR11sortilin-related receptor, L(DLR class) A repeats containingsorting protein-related recept | centrosomal protein of 164 kDacentrosomal protein 164kDa | |
Modification date | 20180527 | 20180523 | |
UniProtAcc | Q92673 | Q9UPV0 | |
Ensembl transtripts involved in fusion gene | ENST00000260197, ENST00000532451, ENST00000525532, ENST00000532694, ENST00000534286, ENST00000527934, | ENST00000278935, ENST00000533706, | |
Fusion gene scores | * DoF score | 13 X 10 X 7=910 | 3 X 3 X 3=27 |
# samples | 14 | 3 | |
** MAII score | log2(14/910*10)=-2.70043971814109 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/27*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: SORL1 [Title/Abstract] AND CEP164 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | SORL1 | GO:0006605 | protein targeting | 16407538 |
Hgene | SORL1 | GO:0006622 | protein targeting to lysosome | 24523320 |
Hgene | SORL1 | GO:0006892 | post-Golgi vesicle-mediated transport | 17855360 |
Hgene | SORL1 | GO:0014910 | regulation of smooth muscle cell migration | 14764453 |
Hgene | SORL1 | GO:0032091 | negative regulation of protein binding | 16407538 |
Hgene | SORL1 | GO:0034067 | protein localization to Golgi apparatus | 17855360 |
Hgene | SORL1 | GO:0045053 | protein retention in Golgi apparatus | 17855360 |
Hgene | SORL1 | GO:0045732 | positive regulation of protein catabolic process | 24523320 |
Hgene | SORL1 | GO:0051604 | protein maturation | 17855360 |
Hgene | SORL1 | GO:1902430 | negative regulation of amyloid-beta formation | 16407538|22621900 |
Hgene | SORL1 | GO:1902960 | negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process | 16407538 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | OV | TCGA-VG-A8LO-01A | SORL1 | chr11 | 121367758 | + | CEP164 | chr11 | 117251330 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000260197 | ENST00000278935 | SORL1 | chr11 | 121367758 | + | CEP164 | chr11 | 117251330 | + |
5CDS-3UTR | ENST00000260197 | ENST00000533706 | SORL1 | chr11 | 121367758 | + | CEP164 | chr11 | 117251330 | + |
3UTR-3CDS | ENST00000532451 | ENST00000278935 | SORL1 | chr11 | 121367758 | + | CEP164 | chr11 | 117251330 | + |
3UTR-3UTR | ENST00000532451 | ENST00000533706 | SORL1 | chr11 | 121367758 | + | CEP164 | chr11 | 117251330 | + |
intron-3CDS | ENST00000525532 | ENST00000278935 | SORL1 | chr11 | 121367758 | + | CEP164 | chr11 | 117251330 | + |
intron-3UTR | ENST00000525532 | ENST00000533706 | SORL1 | chr11 | 121367758 | + | CEP164 | chr11 | 117251330 | + |
intron-3CDS | ENST00000532694 | ENST00000278935 | SORL1 | chr11 | 121367758 | + | CEP164 | chr11 | 117251330 | + |
intron-3UTR | ENST00000532694 | ENST00000533706 | SORL1 | chr11 | 121367758 | + | CEP164 | chr11 | 117251330 | + |
intron-3CDS | ENST00000534286 | ENST00000278935 | SORL1 | chr11 | 121367758 | + | CEP164 | chr11 | 117251330 | + |
intron-3UTR | ENST00000534286 | ENST00000533706 | SORL1 | chr11 | 121367758 | + | CEP164 | chr11 | 117251330 | + |
intron-3CDS | ENST00000527934 | ENST00000278935 | SORL1 | chr11 | 121367758 | + | CEP164 | chr11 | 117251330 | + |
intron-3UTR | ENST00000527934 | ENST00000533706 | SORL1 | chr11 | 121367758 | + | CEP164 | chr11 | 117251330 | + |
Top |
FusionProtFeatures for SORL1_CEP164 |
![]() |
Hgene | Tgene |
SORL1 | CEP164 |
Likely to be a multifunctional endocytic receptor, thatmay be implicated in the uptake of lipoproteins and of proteases.Binds LDL, the major cholesterol-carrying lipoprotein of plasma,and transports it into cells by endocytosis. Binds the receptor-associated protein (RAP). Could play a role in cell-cellinteraction. Involved in APP trafficking to and from the Golgiapparatus. It probably acts as a sorting receptor that protectsAPP from trafficking to late endosome and from processing intoamyloid beta, thereby reducing the burden of amyloidogenic peptideformation. Involved in the regulation of smooth muscle cellsmigration, probably through PLAUR binding and decreasedinternalization. {ECO:0000269|PubMed:14764453,ECO:0000269|PubMed:16174740}. | Plays a role in microtubule organization and/ormaintenance for the formation of primary cilia (PC), amicrotubule-based structure that protrudes from the surface ofepithelial cells. Plays a critical role in G2/M checkpoint andnuclear divisions. A key player in the DNA damage-activatedATR/ATM signaling cascade since it is required for the properphosphorylation of H2AX, RPA, CHEK2 and CHEK1. Plays a criticalrole in chromosome segregation, acting as a mediator required forthe maintenance of genomic stability through modulation of MDC1,RPA and CHEK1. {ECO:0000269|PubMed:17954613,ECO:0000269|PubMed:18283122, ECO:0000269|PubMed:23348840}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | SORL1 | chr11:121367758 | chr11:117251330 | ENST00000260197 | + | 6 | 48 | 63_65 | 313 | 2215 | Motif | Cell attachment site |
Hgene | SORL1 | chr11:121367758 | chr11:117251330 | ENST00000260197 | + | 6 | 48 | 136_147 | 313 | 2215 | Repeat | Note=BNR 1 |
Hgene | SORL1 | chr11:121367758 | chr11:117251330 | ENST00000260197 | + | 6 | 48 | 232_243 | 313 | 2215 | Repeat | Note=BNR 2 |
Tgene | >CEP164 | chr11:121367758 | chr11:117251330 | ENST00000278935 | + | 10 | 33 | 1154_1206 | 439 | 1461 | Coiled coil | Ontology_term=ECO:0000255 |
Tgene | >CEP164 | chr11:121367758 | chr11:117251330 | ENST00000278935 | + | 10 | 33 | 468_955 | 439 | 1461 | Compositional bias | Note=Glu-rich |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | >SORL1 | chr11:121367758 | chr11:117251330 | ENST00000260197 | + | 6 | 48 | 1026_1072 | 313 | 2215 | Domain | Note=EGF-like |
Hgene | >SORL1 | chr11:121367758 | chr11:117251330 | ENST00000260197 | + | 6 | 48 | 1076_1114 | 313 | 2215 | Domain | LDL-receptor class A 1 |
Hgene | >SORL1 | chr11:121367758 | chr11:117251330 | ENST00000260197 | + | 6 | 48 | 1115_1155 | 313 | 2215 | Domain | LDL-receptor class A 2 |
Hgene | >SORL1 | chr11:121367758 | chr11:117251330 | ENST00000260197 | + | 6 | 48 | 1156_1194 | 313 | 2215 | Domain | LDL-receptor class A 3 |
Hgene | >SORL1 | chr11:121367758 | chr11:117251330 | ENST00000260197 | + | 6 | 48 | 1198_1236 | 313 | 2215 | Domain | LDL-receptor class A 4 |
Hgene | >SORL1 | chr11:121367758 | chr11:117251330 | ENST00000260197 | + | 6 | 48 | 1238_1272 | 313 | 2215 | Domain | LDL-receptor class A 5 |
Hgene | >SORL1 | chr11:121367758 | chr11:117251330 | ENST00000260197 | + | 6 | 48 | 1273_1317 | 313 | 2215 | Domain | LDL-receptor class A 6 |
Hgene | >SORL1 | chr11:121367758 | chr11:117251330 | ENST00000260197 | + | 6 | 48 | 1323_1361 | 313 | 2215 | Domain | LDL-receptor class A 7 |
Hgene | >SORL1 | chr11:121367758 | chr11:117251330 | ENST00000260197 | + | 6 | 48 | 1366_1405 | 313 | 2215 | Domain | LDL-receptor class A 8 |
Hgene | >SORL1 | chr11:121367758 | chr11:117251330 | ENST00000260197 | + | 6 | 48 | 1417_1455 | 313 | 2215 | Domain | LDL-receptor class A 9 |
Hgene | >SORL1 | chr11:121367758 | chr11:117251330 | ENST00000260197 | + | 6 | 48 | 1469_1508 | 313 | 2215 | Domain | LDL-receptor class A 10 |
Hgene | >SORL1 | chr11:121367758 | chr11:117251330 | ENST00000260197 | + | 6 | 48 | 1512_1551 | 313 | 2215 | Domain | LDL-receptor class A 11 |
Hgene | >SORL1 | chr11:121367758 | chr11:117251330 | ENST00000260197 | + | 6 | 48 | 1557_1649 | 313 | 2215 | Domain | Fibronectin type-III 1 |
Hgene | >SORL1 | chr11:121367758 | chr11:117251330 | ENST00000260197 | + | 6 | 48 | 1653_1745 | 313 | 2215 | Domain | Fibronectin type-III 2 |
Hgene | >SORL1 | chr11:121367758 | chr11:117251330 | ENST00000260197 | + | 6 | 48 | 1749_1844 | 313 | 2215 | Domain | Fibronectin type-III 3 |
Hgene | >SORL1 | chr11:121367758 | chr11:117251330 | ENST00000260197 | + | 6 | 48 | 1843_1927 | 313 | 2215 | Domain | Fibronectin type-III 4 |
Hgene | >SORL1 | chr11:121367758 | chr11:117251330 | ENST00000260197 | + | 6 | 48 | 1934_2029 | 313 | 2215 | Domain | Fibronectin type-III 5 |
Hgene | >SORL1 | chr11:121367758 | chr11:117251330 | ENST00000260197 | + | 6 | 48 | 2030_2118 | 313 | 2215 | Domain | Fibronectin type-III 6 |
Hgene | >SORL1 | chr11:121367758 | chr11:117251330 | ENST00000260197 | + | 6 | 48 | 2172_2177 | 313 | 2215 | Motif | Endocytosis signal |
Hgene | >SORL1 | chr11:121367758 | chr11:117251330 | ENST00000260197 | + | 6 | 48 | 441_452 | 313 | 2215 | Repeat | Note=BNR 3 |
Hgene | >SORL1 | chr11:121367758 | chr11:117251330 | ENST00000260197 | + | 6 | 48 | 521_532 | 313 | 2215 | Repeat | Note=BNR 4 |
Hgene | >SORL1 | chr11:121367758 | chr11:117251330 | ENST00000260197 | + | 6 | 48 | 562_573 | 313 | 2215 | Repeat | Note=BNR 5 |
Hgene | >SORL1 | chr11:121367758 | chr11:117251330 | ENST00000260197 | + | 6 | 48 | 800_843 | 313 | 2215 | Repeat | Note=LDL-receptor class B 1 |
Hgene | >SORL1 | chr11:121367758 | chr11:117251330 | ENST00000260197 | + | 6 | 48 | 844_887 | 313 | 2215 | Repeat | Note=LDL-receptor class B 2 |
Hgene | >SORL1 | chr11:121367758 | chr11:117251330 | ENST00000260197 | + | 6 | 48 | 888_932 | 313 | 2215 | Repeat | Note=LDL-receptor class B 3 |
Hgene | >SORL1 | chr11:121367758 | chr11:117251330 | ENST00000260197 | + | 6 | 48 | 933_970 | 313 | 2215 | Repeat | Note=LDL-receptor class B 4 |
Hgene | >SORL1 | chr11:121367758 | chr11:117251330 | ENST00000260197 | + | 6 | 48 | 971_1013 | 313 | 2215 | Repeat | Note=LDL-receptor class B 5 |
Hgene | >SORL1 | chr11:121367758 | chr11:117251330 | ENST00000260197 | + | 6 | 48 | 2159_2214 | 313 | 2215 | Topological domain | Cytoplasmic |
Hgene | >SORL1 | chr11:121367758 | chr11:117251330 | ENST00000260197 | + | 6 | 48 | 82_2137 | 313 | 2215 | Topological domain | Extracellular |
Hgene | >SORL1 | chr11:121367758 | chr11:117251330 | ENST00000260197 | + | 6 | 48 | 2138_2158 | 313 | 2215 | Transmembrane | Helical |
Tgene | CEP164 | chr11:121367758 | chr11:117251330 | ENST00000278935 | + | 10 | 33 | 110_122 | 439 | 1461 | Compositional bias | Note=Lys-rich |
Tgene | CEP164 | chr11:121367758 | chr11:117251330 | ENST00000278935 | + | 10 | 33 | 56_89 | 439 | 1461 | Domain | WW |
Top |
FusionGeneSequence for SORL1_CEP164 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
>In-frame_SORL1_ENST00000260197_chr11_121367758_+_CEP164_ENST00000278935_chr11_117251330_+_1335aa MATRSSRRESRLPFLFTLVALLPPGALCEVWTQRLHGGSAPLPQDRGFLVVQGDPRELRLWARGDARGASRADEKPLRRKRSAALQPEPI KVYGQVSLNDSHNQMVVHWAGEKSNVIVALARDSLALARPKSSDVYVSYDYGKSFKKISDKLNFGLGNRSEAVIAQFYHSPADNKRYIFA DAYAQYLWITFDFCNTLQGFSIPFRAADLLLHSKASNLLLGFDRSHPNKQLWKSDDFGQTWIMIQEHVKSFSWGIDPYDKPNTIYIERHE PSGYSTVFRSTDFFQSRENQEVILEEVRDFQLRDKYMFATKVVAQQPLGIEDKDDSQSSQDELQSKQSKGLEERLSPPLPHEERAQSPPR SLATEEEPPQGPEGQPEWKEAEELGEDSAASLSLQLSLQREQAPSPPAACEKGKEQHSQAEELGPGQEEAEDPEEKVAVSPTPPVSPEVR STEPVAPPEQLSEAALKAMEEAVAQVLEQDQRHLLESKQEKMQQLREKLCQEEEEEILRLHQQKEQSLSSLRERLQKAIEEEEARMREEE SQRLSWLRAQVQSSTQADEDQIRAEQEASLQKLREELESQQKAERASLEQKNRQMLEQLKEEIEASEKSEQAALNAAKEKALQQLREQLE GERKEAVATLEKEHSAELERLCSSLEAKHREVVSSLQKKIQEAQQKEEAQLQKCLGQVEHRVHQKSYHVAGYEHELSSLLREKRQEVEGE HERRLDKMKEEHQQVMAKAREQYEAEERKQRAELLGHLTGELERLQRAHERELETVRQEQHKRLEDLRRRHREQERKLQDLELDLETRAK DVKARLALLEVQEETARREKQQLLDVQRQVALKSEEATATHQQLEEAQKEHTHLLQSNQQLREILDELQARKLKLESQVDLLQAQSQQLQ KHFSSLEAEAQKKQHLLREVTVEENNASPHFEPDLHIEDLRKSLGTNQTKEVSSSLSQSKEDLYLDSLSSHNVWHLLSAEGVALRSAKEF LVQQTRSMRRRQTALKAAQQHWRHELASAQEVAKDPPGIKALEDMRKNLEKETRHLDEMKSAMRKGHNLLKKKEEKLNQLESSLWEEASD EGTLGGSPTKKAVTFDLSDMDSLSSESSESFSPPHREWWRQQRIDSTPSLTSRKIHGLSHSLRQISSQLSSVLSILDSLNPQSPPPLLAS MPAQLPPRDPKSTPTPTYYGSLARFSALSSATPTSTQWAWDSGQGPRLPSSVAQTVDDFLLEKWRKYFPSGIPLLSNSPTPLESRLGYMS |
* Fusion transcript sequences (only coding sequence (CDS) region). |
>In-frame_SORL1_ENST00000260197_chr11_121367758_+_CEP164_ENST00000278935_chr11_117251330_+_4005nt ATGGCGACACGGAGCAGCAGGAGGGAGTCGCGACTCCCGTTCCTATTCACCCTGGTCGCACTGCTGCCGCCCGGAGCTCTCTGCGAAGTC TGGACGCAGAGGCTGCACGGCGGCAGCGCGCCCTTGCCCCAGGACCGGGGCTTCCTCGTGGTGCAGGGCGACCCGCGCGAGCTGCGGCTG TGGGCGCGCGGGGATGCCAGGGGGGCGAGCCGCGCGGACGAGAAGCCGCTCCGGAGGAAACGGAGCGCTGCCCTGCAGCCCGAGCCCATC AAGGTGTACGGACAGGTTAGTCTGAATGATTCCCACAATCAGATGGTGGTGCACTGGGCTGGAGAGAAAAGCAACGTGATCGTGGCCTTG GCCCGAGATAGCCTGGCATTGGCGAGGCCCAAGAGCAGTGATGTGTACGTGTCTTACGACTATGGAAAATCATTCAAGAAAATTTCAGAC AAGTTAAACTTTGGCTTGGGAAATAGGAGTGAAGCTGTTATCGCCCAGTTCTACCACAGCCCTGCGGACAACAAGCGGTACATCTTTGCA GACGCTTATGCCCAGTACCTCTGGATCACGTTTGACTTCTGCAACACTCTTCAAGGCTTTTCCATCCCATTTCGGGCAGCTGATCTCCTC CTACACAGTAAGGCCTCCAACCTTCTCTTGGGCTTTGACAGGTCCCACCCCAACAAGCAGCTGTGGAAGTCAGATGACTTTGGCCAGACC TGGATCATGATTCAGGAACATGTCAAGTCCTTTTCTTGGGGAATTGATCCCTATGACAAACCAAATACCATCTACATTGAACGACATGAA CCCTCTGGCTACTCCACTGTCTTCCGAAGTACAGATTTCTTCCAGTCCCGGGAAAACCAGGAAGTGATCCTTGAGGAAGTGAGAGATTTT CAGCTTCGGGACAAGTACATGTTTGCTACAAAGGTGGTGGCCCAGCAACCACTGGGAATAGAAGACAAGGATGACAGCCAGTCCAGCCAA GATGAGCTGCAGAGCAAGCAGTCCAAAGGCCTGGAGGAGAGGTTATCTCCTCCACTTCCACACGAGGAGCGGGCCCAGAGTCCCCCTCGC AGCCTGGCCACTGAAGAAGAGCCTCCCCAGGGCCCCGAGGGGCAGCCCGAGTGGAAGGAGGCAGAGGAGCTTGGGGAGGACTCTGCAGCC AGCCTCAGCCTGCAGCTGTCCCTCCAGAGGGAGCAGGCCCCAAGCCCACCTGCTGCCTGTGAGAAGGGCAAGGAGCAGCATTCCCAGGCC GAGGAGCTGGGCCCTGGGCAGGAAGAGGCAGAGGATCCTGAGGAGAAGGTGGCGGTCAGCCCCACCCCGCCAGTCTCTCCAGAGGTGCGA TCCACAGAGCCTGTGGCTCCCCCAGAGCAGCTCTCAGAGGCTGCACTAAAGGCCATGGAAGAGGCAGTGGCCCAAGTACTCGAGCAAGAC CAGAGGCACCTGCTGGAATCCAAGCAAGAGAAGATGCAGCAACTGCGGGAGAAGCTGTGCCAAGAGGAGGAAGAGGAGATCCTCCGGCTT CACCAGCAGAAAGAGCAATCTCTCAGTTCCTTGAGGGAGCGGCTGCAGAAAGCCATTGAGGAGGAGGAGGCCCGGATGAGAGAGGAGGAA AGCCAGAGGCTATCCTGGCTCCGAGCTCAGGTCCAGTCCAGCACACAAGCAGATGAGGACCAAATCAGGGCTGAGCAAGAGGCTTCCCTG CAGAAACTGAGAGAAGAGTTGGAGTCTCAACAGAAGGCTGAGAGGGCCAGCTTGGAACAGAAAAATAGGCAAATGCTGGAGCAGCTCAAG GAAGAGATAGAGGCTTCGGAGAAGAGCGAGCAGGCTGCCCTGAATGCTGCAAAGGAGAAGGCTCTGCAGCAGCTGAGGGAGCAGCTGGAA GGGGAGAGGAAAGAAGCTGTGGCAACGCTGGAGAAGGAGCACAGTGCTGAGCTGGAGCGGCTCTGCTCCTCATTGGAGGCCAAGCACCGG GAGGTGGTCTCCAGCCTCCAGAAGAAGATACAGGAAGCTCAACAGAAAGAGGAGGCCCAGCTGCAGAAGTGCCTTGGGCAAGTGGAGCAC AGAGTTCACCAGAAGTCTTATCACGTGGCTGGGTATGAGCACGAGCTCAGCAGTCTCCTGCGAGAGAAGCGCCAGGAAGTGGAAGGGGAG CATGAGAGGAGGTTGGACAAGATGAAGGAGGAGCACCAGCAAGTGATGGCTAAGGCCAGAGAGCAGTATGAAGCTGAGGAGAGGAAGCAG CGGGCTGAGCTTCTGGGGCACCTGACCGGAGAGCTGGAGCGCCTGCAGAGGGCCCATGAACGAGAACTGGAGACTGTGAGGCAGGAGCAA CACAAGCGTCTTGAGGACTTGCGGCGCCGGCACAGGGAGCAGGAAAGGAAGCTCCAGGATTTAGAGTTGGACCTTGAAACCAGAGCTAAA GATGTCAAGGCCAGATTGGCTCTGCTGGAGGTCCAGGAGGAGACCGCCCGGAGGGAGAAGCAGCAGCTGCTTGATGTGCAGAGGCAGGTT GCTCTGAAGAGTGAGGAAGCCACAGCCACCCATCAGCAGCTGGAGGAGGCACAGAAGGAGCACACCCACCTGTTGCAGTCAAACCAGCAG CTCCGAGAAATTCTTGATGAGCTGCAGGCCCGCAAGCTGAAGCTGGAGTCCCAAGTGGATCTGCTGCAGGCTCAGAGCCAGCAACTGCAG AAACACTTCAGCAGCCTGGAGGCTGAAGCTCAAAAGAAGCAGCACCTGTTGAGAGAAGTGACAGTTGAGGAAAATAATGCTTCCCCACAT TTTGAGCCAGATCTCCATATTGAGGACCTGAGGAAATCCCTTGGAACAAACCAGACCAAAGAGGTGTCTTCTTCTCTCTCCCAGAGCAAG GAGGACTTATACTTGGACAGCCTGTCCTCCCACAATGTCTGGCACCTCCTCTCTGCTGAGGGGGTAGCCCTCCGTAGTGCCAAGGAGTTC CTTGTGCAGCAGACACGCTCCATGCGGAGGCGGCAGACAGCTCTGAAAGCTGCCCAGCAGCATTGGCGCCATGAGCTGGCCAGTGCGCAG GAGGTGGCCAAAGACCCACCAGGCATCAAGGCCCTGGAAGATATGCGCAAGAACCTGGAGAAGGAGACCAGGCACCTGGATGAGATGAAG TCGGCCATGCGGAAAGGCCACAACCTGCTGAAGAAGAAAGAGGAGAAGCTGAATCAGTTGGAGTCCTCTCTTTGGGAAGAGGCCTCAGAT GAGGGCACTCTGGGAGGATCCCCCACCAAGAAGGCAGTAACCTTCGACCTCAGTGACATGGACAGCCTGAGCAGTGAAAGTTCTGAATCT TTTTCCCCGCCTCACCGTGAGTGGTGGCGGCAGCAGAGGATCGACTCAACCCCGAGTCTCACCTCCCGCAAGATCCACGGGCTTAGCCAC TCCCTCCGGCAGATCAGCAGCCAGCTGAGCAGTGTCCTCAGCATCCTGGACAGCCTCAACCCTCAGTCGCCGCCGCCGCTCCTCGCCTCC ATGCCAGCCCAGCTCCCTCCCCGGGACCCTAAGAGCACCCCCACCCCCACCTACTATGGCTCCCTGGCCAGGTTCTCAGCCTTATCATCT GCTACACCCACGTCCACCCAATGGGCCTGGGATTCAGGGCAGGGGCCCAGGCTCCCCTCCTCTGTGGCTCAAACGGTGGACGACTTCCTG TTGGAGAAGTGGCGCAAGTATTTTCCATCTGGCATCCCGCTGCTCAGCAACAGCCCCACCCCGCTGGAGAGCAGGCTGGGTTACATGTCT GCCAGTGAGCAGCTCCGGCTCCTACAGCACTCCCATTCGCAAGTCCCTGAGGCGGGCAGCACCACCTTTCAGGGCATAATTGAGGCCAAC CGGAGGTGGCTGGAACGTGTCAAGAATGACCCCAGGTTACCTCTCTTCTCGTCAACACCCAAGCCAAAAGCTACTTTGAGCCTCCTGCAG |
* Fusion transcript sequences (Full-length transcript). |
>In-frame_SORL1_ENST00000260197_chr11_121367758_+_CEP164_ENST00000278935_chr11_117251330_+_5234nt CCCGGAGCGGCGCGGGCGGCCTGGAGCCCCGGGAGCGGCGCGCGCGGTCCCGGCCCAGCGGCTCTCCTGGCCTCGCGCTGCACATTCTCT CCTGGCGGCGGCGCCACCTGCAGTAGCGTTCGCCCGAACATGGCGACACGGAGCAGCAGGAGGGAGTCGCGACTCCCGTTCCTATTCACC CTGGTCGCACTGCTGCCGCCCGGAGCTCTCTGCGAAGTCTGGACGCAGAGGCTGCACGGCGGCAGCGCGCCCTTGCCCCAGGACCGGGGC TTCCTCGTGGTGCAGGGCGACCCGCGCGAGCTGCGGCTGTGGGCGCGCGGGGATGCCAGGGGGGCGAGCCGCGCGGACGAGAAGCCGCTC CGGAGGAAACGGAGCGCTGCCCTGCAGCCCGAGCCCATCAAGGTGTACGGACAGGTTAGTCTGAATGATTCCCACAATCAGATGGTGGTG CACTGGGCTGGAGAGAAAAGCAACGTGATCGTGGCCTTGGCCCGAGATAGCCTGGCATTGGCGAGGCCCAAGAGCAGTGATGTGTACGTG TCTTACGACTATGGAAAATCATTCAAGAAAATTTCAGACAAGTTAAACTTTGGCTTGGGAAATAGGAGTGAAGCTGTTATCGCCCAGTTC TACCACAGCCCTGCGGACAACAAGCGGTACATCTTTGCAGACGCTTATGCCCAGTACCTCTGGATCACGTTTGACTTCTGCAACACTCTT CAAGGCTTTTCCATCCCATTTCGGGCAGCTGATCTCCTCCTACACAGTAAGGCCTCCAACCTTCTCTTGGGCTTTGACAGGTCCCACCCC AACAAGCAGCTGTGGAAGTCAGATGACTTTGGCCAGACCTGGATCATGATTCAGGAACATGTCAAGTCCTTTTCTTGGGGAATTGATCCC TATGACAAACCAAATACCATCTACATTGAACGACATGAACCCTCTGGCTACTCCACTGTCTTCCGAAGTACAGATTTCTTCCAGTCCCGG GAAAACCAGGAAGTGATCCTTGAGGAAGTGAGAGATTTTCAGCTTCGGGACAAGTACATGTTTGCTACAAAGGTGGTGGCCCAGCAACCA CTGGGAATAGAAGACAAGGATGACAGCCAGTCCAGCCAAGATGAGCTGCAGAGCAAGCAGTCCAAAGGCCTGGAGGAGAGGTTATCTCCT CCACTTCCACACGAGGAGCGGGCCCAGAGTCCCCCTCGCAGCCTGGCCACTGAAGAAGAGCCTCCCCAGGGCCCCGAGGGGCAGCCCGAG TGGAAGGAGGCAGAGGAGCTTGGGGAGGACTCTGCAGCCAGCCTCAGCCTGCAGCTGTCCCTCCAGAGGGAGCAGGCCCCAAGCCCACCT GCTGCCTGTGAGAAGGGCAAGGAGCAGCATTCCCAGGCCGAGGAGCTGGGCCCTGGGCAGGAAGAGGCAGAGGATCCTGAGGAGAAGGTG GCGGTCAGCCCCACCCCGCCAGTCTCTCCAGAGGTGCGATCCACAGAGCCTGTGGCTCCCCCAGAGCAGCTCTCAGAGGCTGCACTAAAG GCCATGGAAGAGGCAGTGGCCCAAGTACTCGAGCAAGACCAGAGGCACCTGCTGGAATCCAAGCAAGAGAAGATGCAGCAACTGCGGGAG AAGCTGTGCCAAGAGGAGGAAGAGGAGATCCTCCGGCTTCACCAGCAGAAAGAGCAATCTCTCAGTTCCTTGAGGGAGCGGCTGCAGAAA GCCATTGAGGAGGAGGAGGCCCGGATGAGAGAGGAGGAAAGCCAGAGGCTATCCTGGCTCCGAGCTCAGGTCCAGTCCAGCACACAAGCA GATGAGGACCAAATCAGGGCTGAGCAAGAGGCTTCCCTGCAGAAACTGAGAGAAGAGTTGGAGTCTCAACAGAAGGCTGAGAGGGCCAGC TTGGAACAGAAAAATAGGCAAATGCTGGAGCAGCTCAAGGAAGAGATAGAGGCTTCGGAGAAGAGCGAGCAGGCTGCCCTGAATGCTGCA AAGGAGAAGGCTCTGCAGCAGCTGAGGGAGCAGCTGGAAGGGGAGAGGAAAGAAGCTGTGGCAACGCTGGAGAAGGAGCACAGTGCTGAG CTGGAGCGGCTCTGCTCCTCATTGGAGGCCAAGCACCGGGAGGTGGTCTCCAGCCTCCAGAAGAAGATACAGGAAGCTCAACAGAAAGAG GAGGCCCAGCTGCAGAAGTGCCTTGGGCAAGTGGAGCACAGAGTTCACCAGAAGTCTTATCACGTGGCTGGGTATGAGCACGAGCTCAGC AGTCTCCTGCGAGAGAAGCGCCAGGAAGTGGAAGGGGAGCATGAGAGGAGGTTGGACAAGATGAAGGAGGAGCACCAGCAAGTGATGGCT AAGGCCAGAGAGCAGTATGAAGCTGAGGAGAGGAAGCAGCGGGCTGAGCTTCTGGGGCACCTGACCGGAGAGCTGGAGCGCCTGCAGAGG GCCCATGAACGAGAACTGGAGACTGTGAGGCAGGAGCAACACAAGCGTCTTGAGGACTTGCGGCGCCGGCACAGGGAGCAGGAAAGGAAG CTCCAGGATTTAGAGTTGGACCTTGAAACCAGAGCTAAAGATGTCAAGGCCAGATTGGCTCTGCTGGAGGTCCAGGAGGAGACCGCCCGG AGGGAGAAGCAGCAGCTGCTTGATGTGCAGAGGCAGGTTGCTCTGAAGAGTGAGGAAGCCACAGCCACCCATCAGCAGCTGGAGGAGGCA CAGAAGGAGCACACCCACCTGTTGCAGTCAAACCAGCAGCTCCGAGAAATTCTTGATGAGCTGCAGGCCCGCAAGCTGAAGCTGGAGTCC CAAGTGGATCTGCTGCAGGCTCAGAGCCAGCAACTGCAGAAACACTTCAGCAGCCTGGAGGCTGAAGCTCAAAAGAAGCAGCACCTGTTG AGAGAAGTGACAGTTGAGGAAAATAATGCTTCCCCACATTTTGAGCCAGATCTCCATATTGAGGACCTGAGGAAATCCCTTGGAACAAAC CAGACCAAAGAGGTGTCTTCTTCTCTCTCCCAGAGCAAGGAGGACTTATACTTGGACAGCCTGTCCTCCCACAATGTCTGGCACCTCCTC TCTGCTGAGGGGGTAGCCCTCCGTAGTGCCAAGGAGTTCCTTGTGCAGCAGACACGCTCCATGCGGAGGCGGCAGACAGCTCTGAAAGCT GCCCAGCAGCATTGGCGCCATGAGCTGGCCAGTGCGCAGGAGGTGGCCAAAGACCCACCAGGCATCAAGGCCCTGGAAGATATGCGCAAG AACCTGGAGAAGGAGACCAGGCACCTGGATGAGATGAAGTCGGCCATGCGGAAAGGCCACAACCTGCTGAAGAAGAAAGAGGAGAAGCTG AATCAGTTGGAGTCCTCTCTTTGGGAAGAGGCCTCAGATGAGGGCACTCTGGGAGGATCCCCCACCAAGAAGGCAGTAACCTTCGACCTC AGTGACATGGACAGCCTGAGCAGTGAAAGTTCTGAATCTTTTTCCCCGCCTCACCGTGAGTGGTGGCGGCAGCAGAGGATCGACTCAACC CCGAGTCTCACCTCCCGCAAGATCCACGGGCTTAGCCACTCCCTCCGGCAGATCAGCAGCCAGCTGAGCAGTGTCCTCAGCATCCTGGAC AGCCTCAACCCTCAGTCGCCGCCGCCGCTCCTCGCCTCCATGCCAGCCCAGCTCCCTCCCCGGGACCCTAAGAGCACCCCCACCCCCACC TACTATGGCTCCCTGGCCAGGTTCTCAGCCTTATCATCTGCTACACCCACGTCCACCCAATGGGCCTGGGATTCAGGGCAGGGGCCCAGG CTCCCCTCCTCTGTGGCTCAAACGGTGGACGACTTCCTGTTGGAGAAGTGGCGCAAGTATTTTCCATCTGGCATCCCGCTGCTCAGCAAC AGCCCCACCCCGCTGGAGAGCAGGCTGGGTTACATGTCTGCCAGTGAGCAGCTCCGGCTCCTACAGCACTCCCATTCGCAAGTCCCTGAG GCGGGCAGCACCACCTTTCAGGGCATAATTGAGGCCAACCGGAGGTGGCTGGAACGTGTCAAGAATGACCCCAGGTTACCTCTCTTCTCG TCAACACCCAAGCCAAAAGCTACTTTGAGCCTCCTGCAGCTGGGCCTTGATGAGCACAACAGAGTGAAGGTGTATCGCTTCTGAGGCCCT GAGCAGGGGCTTGGGGCAGCCCAGCCTCTCCTCCACCCAGACCAAGTGCCTGAGGAGCTGCCTGCCTTCTTCCATCTGAGAAAGCACCCT CCTTCCCCCTTTGACTTGCAGGAGCCACCAGGGACCAGGGGGTTGAGTGGAACAGTAAAGCCACACATTCTGTGACTATATAACCTATCT CAGGCTAAAATGTGTGGACTCGTACGAGCTCTTGTCATTGACATGGCAAGCTGATGGCGTGCGGTGGCTGCGGGGTATCAGGGCCGGGAG CCCTTTGGGAGGAAGGGAGGCGTTAGAGGAGCTGCCTTCGGAGGCTCAGGGAGTCCCTTTGGAGCTGGTTGTTTCCTTGGCCCTGCAGCG CACTGCTCGGGGCTCCCAAGGAGGTTGTGTGTATGGTTCTTAATTCATCAGGACAAAGACCCCCAGCATGTGTGTACCCTGGGACCCGAT TTCTCTGGGCCCACATCTATCTCCAATACCTCAGCCTCAGATCAGACCCTTTCTTTTTTGTCTTTCTTCTCTTAATTTTTAAATGCCTCT TTTCTTGAGCATTCCATCTCTCTTTTTGACCCTCTCAGGACTGGGCTTAGCTGTCCAGAGCCCTGCCGGAGGGTGCTGGGGGCTGTCCCT CTGCAGGCACTGTGTTTTCCTCAGGGGCTGTCCTCAGAACACCCCTCCTGCTCCCTGGGGCTCCTCAGGGAGCCATTTCAGCTGGAGTCT CAGGTCTCAAAAACAACTTCTCCAGGAGGCCAAAAAAAGACTGGGTTGGCTTCTGGTCCTCATGATGGCTTTTATCCTCCTGGGACACTT TGGGTATATTCATGGGCATTGTTTCCATCTGTCTTTTCTACCTGTGCCACCCCTGCCCTGATTCCACGGCTGCCTCAGGCAGGCAGGCAA GGAGCTAGGCCGGTGCCCGGCCCTGGCAGCAAGGGGTCTTTGTGCAGTTGGAGATGCTGCCGTTGTGGCAGAGCGTCCTGCAGCCCCGCT TCCATCAGCAGGCTCTGGGGTGGGGGCTTTGCAGGGGATGCTCTCTGATGTTTGTTCCGTTGTTTAAATAAAATGCACTTATTTTTGTTT |
Top |
FusionGenePPI for SORL1_CEP164 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
SORL1 | LRPAP1, GGA1, GGA2, PPP1CA, CUL1, COPS5, COPS6, FBXO6, CFTR, DYRK3, POP1, AURKA, APP, PACS1, FAM76B, HLA-DPA1, RSPO1, LGALS8, FGL1, LGALS9, DLD, FOSL2, WISP3, SP6, ZFP41, FOXI2, ZNF354C, TYW3, ZNF563, ZNF224, ZNF408, ZNF331, EGFL6, ZNF169, FAM19A3, OS9, ZBBX, ZNF517, ZNF264, PSG1, SREBF1, MDK, SCGB1D1, ZNF816, FAM19A4, SOST, CDHR5, ZNF549, GCNT3, CEP97 | CEP164 | ATR, ATRIP, ELAVL1, UBC, CCDC92, TTBK2, NPHP3, NPHP1, INVS, NPHP4, DVL3, MAPK14, SHMT2, MOV10, LIPH, OFD1, PCM1, CEP128, BTF3, C1orf131, CAPN1, CEBPZ, CTSB, DDX24, DDX47, DNAJB6, EBNA1BP2, GLUD2, IDH3B, LONP1, MTPN, NMD3, NSUN2, PDS5B, PEF1, PPM1F, RBFOX2, RFC2, RPP38, SENP3, SRSF2, SSR3, STX8, WDR3, YY1, AATF, C17orf85, CSRP2, DBT, DDX23, DDX56, ECH1, GPX1, NKRF, NOL11, NUP205, NVL, PDCD11, RPF2, SRSF10, SSRP1, SUPT16H, TBL3, TIMM23B, TOP2B, TRA2B, USP36, VN1R5, ZNF326, CEP89, NIN, NHP2L1, RNASEH2B, LDHD, CDC16, NCAPH2, RFWD2, FAM19A3, RALBP1, THSD4, CRYL1, CELA1, SYCE3, BBS7 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Tgene | CEP164 | chr11:121367758 | chr11:117251330 | ENST00000278935 | + | 10 | 33 | 1_194 | 439 | 1461 | ATRIP |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for SORL1_CEP164 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for SORL1_CEP164 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | SORL1 | C0008370 | Cholestasis | 1 | CTD_human |
Hgene | SORL1 | C0027626 | Neoplasm Invasiveness | 1 | CTD_human |
Hgene | SORL1 | C4277682 | Chemical and Drug Induced Liver Injury | 1 | CTD_human |
Tgene | CEP164 | C3541853 | NEPHRONOPHTHISIS 15 | 1 | UNIPROT |